- ISIN
- US45768S1050
- CUSIP
- 45768S105
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- IPO Date
- May 13, 1998
Highlights
- Market Cap
- $2.05B
- Enterprise Value
- $1.83B
- EPS (TTM)
- $4.58
- PE Ratio
- 17.99
- PEG Ratio
- 0.36
- Total Revenue (TTM)
- $1.79B
- Gross Profit (TTM)
- $490.80M
- EBITDA (TTM)
- $162.50M
- Year Range
- $65.51 - $92.14
- Target Price
- $115.00
- ROA (TTM)
- 6.28%
- ROE (TTM)
- 7.98%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
IOSP Performance Chart
Innospec Inc. (IOSP) is up 9.0% since the beginning of the year. At $82 per share, IOSP is trading 10.5% below its 52-week high of $92. Investors who bought $1,000 worth of IOSP shares 5 years ago would now be looking at an investment worth $950.
Loading charts...
Returns By Period
Innospec Inc. (IOSP) has returned 9.02% so far this year and 2.32% over the past 12 months. Over the last ten years, IOSP has returned 7.57% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Innospec Inc.
- 1D
- -0.31%
- 1M
- 3.63%
- YTD
- 9.02%
- 6M
- 7.14%
- 1Y
- 2.32%
- 3Y*
- -3.61%
- 5Y*
- -1.02%
- 10Y*
- 7.57%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
IOSP Monthly Returns History
Based on dividend-adjusted daily data since May 13, 1998, IOSP's average daily return is +0.07%, while the average monthly return is +1.30%. At this rate, an investment would double in approximately 4.5 years.
Historically, 50% of months were positive and 50% were negative. The best month was Apr 2009 with a return of +108.5%, while the worst month was Nov 2008 at -34.2%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 8 months.
On a daily basis, IOSP closed higher 50% of trading days. The best single day was Dec 16, 2008 with a return of +24.7%, while the worst single day was Jul 31, 2008 at -24.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 6.77% | -6.29% | -4.65% | 4.44% | 10.04% | -0.57% | 9.02% | ||||||
| 2025 | 2.99% | -8.77% | -8.37% | -5.56% | -4.01% | -1.16% | -4.98% | 9.62% | -11.91% | -4.64% | 2.84% | 2.38% | -28.94% |
| 2024 | -5.79% | 7.03% | 3.76% | -6.93% | 9.64% | -5.51% | 6.11% | -12.11% | -1.88% | -4.70% | 10.78% | -7.21% | -9.57% |
| 2023 | 9.88% | -3.15% | -6.20% | -1.01% | -8.48% | 8.75% | 6.67% | 0.26% | -4.86% | -4.11% | 7.93% | 17.29% | 21.46% |
| 2022 | 2.90% | 2.73% | -3.09% | 2.98% | 7.72% | -6.12% | 6.48% | -8.37% | -8.34% | 16.72% | 11.56% | -7.24% | 15.25% |
| 2021 | -3.24% | 14.42% | 2.23% | -5.14% | 4.38% | -10.38% | -2.38% | 5.82% | -10.02% | 7.59% | -9.82% | 11.26% | 0.77% |
Benchmark Metrics
Innospec Inc. has an annualized alpha of 7.00%, beta of 1.13, and R2 of 0.25 versus S&P 500 Index. Calculated based on daily prices since May 13, 1998.
- This stock captured 129.10% of S&P 500 Index gains and 121.88% of its losses - amplifying both gains and losses, but participating more in upside than downside.
- R2 of 0.25 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 7.00%
- Beta
- 1.13
- R²
- 0.25
- Upside Capture
- 129.10%
- Downside Capture
- 121.88%
Return for Risk
Risk / Return Rank
IOSP ranks 43 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Innospec Inc. (IOSP) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IOSP | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.93 | ||
| Sortino ratioReturn per unit of downside risk | -2.43 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.37 | -0.33 |
| Calmar ratioReturn relative to maximum drawdown | 0.09 | 2.78 | -2.69 |
| Martin ratioReturn relative to average drawdown | 0.19 | 12.44 | -12.25 |
Dividends
Dividend History
Innospec Inc. provided a 2.17% dividend yield over the last twelve months, with an annual payout of $1.79 per share. The company has been increasing its dividends for 12 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $1.79 | $1.71 | $1.55 | $1.41 | $1.28 | $1.16 | $1.04 | $1.02 | $0.89 | $0.77 | $0.67 | $0.61 |
Dividend yield | 2.17% | 2.23% | 1.41% | 1.14% | 1.24% | 1.28% | 1.15% | 0.99% | 1.44% | 1.09% | 0.98% | 1.12% |
Monthly Dividends
The table displays the monthly dividend distributions for Innospec Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.92 | $0.00 | $0.92 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.84 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.87 | $0.00 | $1.71 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.76 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.79 | $0.00 | $1.55 |
| 2023 | $0.00 | $0.00 | $0.00 | $0.00 | $0.69 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.72 | $0.00 | $1.41 |
| 2022 | $0.00 | $0.00 | $0.00 | $0.00 | $0.63 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.65 | $0.00 | $1.28 |
| 2021 | $0.00 | $0.00 | $0.00 | $0.00 | $0.57 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.59 | $0.00 | $1.16 |
Dividend Yield & Payout
Dividend Yield
Innospec Inc. has a dividend yield of 2.17%, which is quite average when compared to the overall market.
Payout Ratio
Innospec Inc. has a payout ratio of 37.13%, which is quite average when compared to the overall market. This suggests that Innospec Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Innospec Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Innospec Inc. was 91.17%, occurring on Mar 9, 2009. Recovery took 520 trading sessions.
The current Innospec Inc. drawdown is 34.68%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
Financial crisis2007–2009 | -91.17%Mar 2009 | 1y 7mo | 2y 21d | 3y 8moJul 2007 - Mar 2011 |
Dot-com crash2000–2002 | -76.68%May 2000 | 1y 12mo | 6y 5mo | 8y 5moMay 1998 - Oct 2006 |
2026 bear market2026 | -48.42%Mar 2026 | 1y 7mo | — | 1y 11moJul 2024 - now |
COVID crash2020 | -42.73%Mar 2020 | 1mo 26d | 1y 17d | 1y 2moJan 2020 - Apr 2021 |
2011 bear market2011 | -42.27%Aug 2011 | 3mo 19d | 1y 4mo | 1y 8moMay 2011 - Jan 2013 |
Drawdown Indicators
| IOSP | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -91.17% | -56.78% | -34.39% |
Max Drawdown (1Y)Largest decline over 1 year | -25.48% | -9.10% | -16.38% |
Max Drawdown (3Y)Largest decline over 3 years | -48.42% | -18.90% | -29.52% |
Max Drawdown (5Y)Largest decline over 5 years | -48.42% | -25.43% | -22.99% |
Max Drawdown (10Y)Largest decline over 10 years | -48.42% | -33.92% | -14.50% |
Current DrawdownCurrent decline from peak | -34.68% | -1.80% | -32.88% |
Average DrawdownAverage peak-to-trough decline | -28.68% | -10.71% | -17.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.13% | 2.03% | +10.10% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Innospec Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Innospec Inc. is priced in the market compared to other companies in the Specialty Chemicals industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for IOSP, comparing it with other companies in the Specialty Chemicals industry. Currently, IOSP has a P/E ratio of 18.0. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for IOSP compared to other companies in the Specialty Chemicals industry. IOSP currently has a PEG ratio of 0.4. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for IOSP relative to other companies in the Specialty Chemicals industry. Currently, IOSP has a P/S ratio of 1.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for IOSP in comparison with other companies in the Specialty Chemicals industry. Currently, IOSP has a P/B value of 1.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with IOSP
Add Innospec Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with IOSP